Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-16

FDA Approved: IRBESARTAN — Supplemental Application (Hisun Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for IRBESARTAN from Hisun Pharmaceuticals USA Inc., approving changes to the generic product's approval under the AN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)